ÂÜÀòÂÒÂ×

Slawomir Golda has a diverse work experience in the fields of genome informatics, molecular biology, and bioinformatics. Slawomir co-founded and served as the Chief Operations Officer at intelliseq, a genome informatics company, from 2013 to the present. In 2017, they became the Chief Financial Officer at Intelliseq Corp. Prior to that, from 2009 to 2017, Golda worked as a postdoc NGS specialist and molecular biologist at the Institute of Pharmacology, Polish Academy of Sciences. During their time there, they focused on identifying differences between neurons and glial cells in transcriptional sensitivity to glucocorticoids. Before that, they had an internship as a Clinical Research Associate at MDS Pharma Services in 2009 and worked as a Research Assistant at INSERM from 2005 to 2006.

Slawomir Golda has a strong education background in the field of biotechnology and oncology. Slawomir first pursued their Bachelor's degree in Biotechnology/Biophysics at Jagiellonian University from 1998 to 2003. Building upon this foundation, they then went on to complete their Doctor of Philosophy (Ph.D.) in Oncology and Cancer Biology at the same university from 2003 to 2008. Recently, in 2017 to 2018, they furthered their knowledge by undertaking postgraduate study in Clinical Trials - methodology, organization, and management, again at Jagiellonian University. Through these educational experiences, Slawomir Golda has developed a well-rounded understanding of various aspects of the biotechnology, oncology, and clinical trials fields.